Key facts
- Notable investors include Shenzhen Yuanshan Private Equity Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Guoke Yingrui
- ·The full record, as it builds
Funding rounds
No funding rounds for Guoke Yingrui are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guoke Yingrui
Developer of medical technology platforms intended for drug research and advanced clinical applications. The company offers integrated translational medicine capabilities, collaborative research frameworks, and technical development services across pharmaceutical innovation and clinical trial support, enabling healthcare institutions, biotech enterprises, and research organizations to maintain compliance with stringent medical and regulatory standards.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2017
- Website
- guokeyr.cn/
- Ownership
- Privately Held (backing)
Guoke Yingrui doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guoke Yingrui shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guoke Yingrui in its N-PORT filings yet. We sweep new filings monthly.